Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bulent Ozpolat

Showing results (21-30 of 137) with videos related to

Pageof 14
Sort By:
Anticancer Research|December 4, 2018
Targeted Therapies for Pancreatic Cancer and Hurdles AheadMinela Aslan, Reza Shahbazi, Kezban Ulubayram, et al.
International Journal of Molecular Medicine|April 17, 2013
Response of CD44+/CD24-/low breast cancer stem/progenitor cells to tamoxifen‑ and doxorubicin‑induced autophagyVildan Betul Yenigun, Bulent Ozpolat, Gamze Torun Kose
Molecular Cancer|February 1, 2021
Non-coding RNAs regulation of macrophage polarization in cancerSwati Mohapatra, Carlotta Pioppini, Bulent Ozpolat, et al.
Cancers|August 12, 2022
miRacle of microRNA-Driven Cancer NanotherapeuticsGoknur Kara, Banu Arun, George A Calin, et al.
Journal of Biomolecular Structure & Dynamics|March 19, 2019
Structure prediction of eukaryotic elongation factor-2 kinase and identification of the binding mechanisms of its inhibitors: homology modeling, molecular docking, and molecular dynamics simulationGizem Tatar, Tugba Taskin Tok, Bulent Ozpolat, et al.
Autophagy|May 18, 2007
PKC delta and tissue transglutaminase are novel inhibitors of autophagy in pancreatic cancer cellsBulent Ozpolat, Ugur Akar, Kapil Mehta, et al.
American Journal of Hematology|May 8, 2002
all-trans-Retinoic acid-induced expression and regulation of retinoic acid 4-hydroxylase (CYP26) in human promyelocytic leukemiaBulent Ozpolat, Kapil Mehta, Ana M Tari, et al.
Leukemia & Lymphoma|August 5, 2004
Nuclear retinoid receptors are involved in N-(4-hydroxyphenyl) retinamide (Fenretinide)-induced gene expression and growth inhibition in HL-60 acute myeloid leukemia cellsBulent Ozpolat, Ana M Tari, Kapil Mehta, et al.
Journal of Drug Targeting|October 2, 2013
Nanotechnology in cancer therapyBurcu Aslan, Bulent Ozpolat, Anil K Sood, et al.
Breast Cancer (Tokyo, Japan)|August 25, 2022
Serotonin 5-HT7 receptor is a biomarker poor prognostic factor and induces proliferation of triple-negative breast cancer cells through FOXM1Venhar Cınar, Zuhal Hamurcu, Ahsen Guler, et al.
Pageof 14

Showing results (21-30 of 137) with videos related to

Sort By:
Pageof 14
Anticancer Research|December 4, 2018
Targeted Therapies for Pancreatic Cancer and Hurdles AheadMinela Aslan, Reza Shahbazi, Kezban Ulubayram, et al.
International Journal of Molecular Medicine|April 17, 2013
Response of CD44+/CD24-/low breast cancer stem/progenitor cells to tamoxifen‑ and doxorubicin‑induced autophagyVildan Betul Yenigun, Bulent Ozpolat, Gamze Torun Kose
Molecular Cancer|February 1, 2021
Non-coding RNAs regulation of macrophage polarization in cancerSwati Mohapatra, Carlotta Pioppini, Bulent Ozpolat, et al.
Cancers|August 12, 2022
miRacle of microRNA-Driven Cancer NanotherapeuticsGoknur Kara, Banu Arun, George A Calin, et al.
Journal of Biomolecular Structure & Dynamics|March 19, 2019
Structure prediction of eukaryotic elongation factor-2 kinase and identification of the binding mechanisms of its inhibitors: homology modeling, molecular docking, and molecular dynamics simulationGizem Tatar, Tugba Taskin Tok, Bulent Ozpolat, et al.
Autophagy|May 18, 2007
PKC delta and tissue transglutaminase are novel inhibitors of autophagy in pancreatic cancer cellsBulent Ozpolat, Ugur Akar, Kapil Mehta, et al.
American Journal of Hematology|May 8, 2002
all-trans-Retinoic acid-induced expression and regulation of retinoic acid 4-hydroxylase (CYP26) in human promyelocytic leukemiaBulent Ozpolat, Kapil Mehta, Ana M Tari, et al.
Leukemia & Lymphoma|August 5, 2004
Nuclear retinoid receptors are involved in N-(4-hydroxyphenyl) retinamide (Fenretinide)-induced gene expression and growth inhibition in HL-60 acute myeloid leukemia cellsBulent Ozpolat, Ana M Tari, Kapil Mehta, et al.
Journal of Drug Targeting|October 2, 2013
Nanotechnology in cancer therapyBurcu Aslan, Bulent Ozpolat, Anil K Sood, et al.
Breast Cancer (Tokyo, Japan)|August 25, 2022
Serotonin 5-HT7 receptor is a biomarker poor prognostic factor and induces proliferation of triple-negative breast cancer cells through FOXM1Venhar Cınar, Zuhal Hamurcu, Ahsen Guler, et al.
Pageof 14